Literature DB >> 18456123

Current utilization of reconstructive upper limb surgery in tetraplegia.

Lee Squitieri1, Kevin C Chung.   

Abstract

Despite improved surgical techniques and postoperative management protocols for tetraplegic patients undergoing upper extremity functional reconstruction, recent studies have shown that these procedures are profoundly underutilized in the United States. The complex disabilities of tetraplegic patients limit their ability to independently obtain treatment information and travel to medical destinations to receive reconstructive procedures, thus making them a vulnerable patient population susceptible to physician influence regarding treatment decisions. Based on the results of previous research, we believe that increased collaboration among treating physician specialties will enhance patient access to surgical reconstruction.

Entities:  

Mesh:

Year:  2008        PMID: 18456123     DOI: 10.1016/j.hcl.2008.01.001

Source DB:  PubMed          Journal:  Hand Clin        ISSN: 0749-0712            Impact factor:   1.907


  4 in total

1.  Trends in Utilization of Upper Extremity Reconstructive Surgery Following Traumatic Brain Injury and Stroke.

Authors:  Bryan G Beutel; Bryan J Marascalchi; Eitan Melamed
Journal:  Hand (N Y)       Date:  2018-07-19

2.  Essential gains and health after upper-limb tetraplegia surgery identified by the International classification of functioning, disability and health (ICF).

Authors:  L Bunketorp-Käll; C Reinholdt; J Fridén; J Wangdell
Journal:  Spinal Cord       Date:  2017-04-18       Impact factor: 2.772

3.  Nerve transfers in tetraplegia I: Background and technique.

Authors:  Justin M Brown
Journal:  Surg Neurol Int       Date:  2011-08-30

4.  Voluntary activation of biceps-to-triceps and deltoid-to-triceps transfers in quadriplegia.

Authors:  Carrie L Peterson; Michael S Bednar; Anne M Bryden; Michael W Keith; Eric J Perreault; Wendy M Murray
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.